¼¼°èÀÇ µ¿¹°¿ë ¾à¹°°¨½Ã ½ÃÀå º¸°í¼­(2025³â)
Veterinary Pharmacovigilance Global Market Report 2025
»óǰÄÚµå : 1717354
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,219,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 8,990,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,761,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

µ¿¹°¿ë ¾à¹°°¨½Ã ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ ±Þ¼ºÀåÀÌ Àü¸ÁµÉ ¿¹Á¤ÀÔ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â µðÁöÅÐ º¸°í ½Ã½ºÅÛÀÇ Ã¤ÅÃ, Áü½Â ÀÇ·á¿ë ¿ø°Ý ÀÇ·á ¼­ºñ½º È®´ë, µ¥ÀÌÅÍ º¸¾ÈÀ» À§ÇÑ ºí·ÏüÀÎ ÅëÇÕ, Ŭ¶ó¿ìµå ¾à¹°°¨½Ã Ç÷§Æû °³¹ß µîÀÌ ÀÖ½À´Ï´Ù.

µ¿¹°ÀÇ °Ç°­°ú ÀǾàǰ Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â µ¿¹°¿ë ¾à¹°°¨½Ã ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¿ä Áõ°¡´Â ¹Ý·Áµ¿¹°ÀÇ »çÀ°¼ö Áõ°¡, ¼öÀÇÇÐÀÇ Áøº¸, °¡ÃàÀÇ »ý»ê¼ºÀ» ³ôÀÏ Çʿ伺 µîÀÌ ¹è°æ¿¡ ÀÖ½À´Ï´Ù. ºÎÀÛ¿ëÀÇ ¸ð´ÏÅ͸µ°ú Æò°¡, ±ÔÁ¦ ÁؼöÀÇ Ã¶Àú¸¦ ÅëÇØ ÀǾàǰÀÇ ¾ÈÀü¼º°ú À¯È¿¼ºÀ» È®º¸ÇÔÀ¸·Î½á ¹Ý·Áµ¿¹° Äɾ¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 3¿ù ¿¡½ºÅä´Ï¾Æ ÀǾàǰû(Ravimiamet)Àº 2023³â µ¿¹°¿ë ÀǾàǰ ºÎ¹®ÀÌ 2022³â 1,740¸¸ À¯·Î¿¡ ºñÇØ 6.9% ¼ºÀåÇÏ¿© 1,860¸¸ À¯·Î¸¦ ±â·ÏÇß´Ù°í º¸°íÇß½À´Ï´Ù.

µ¿¹°¿ë ¾à¹°°¨½Ã ºÎ¹®ÀÇ ÁÖ¿ä ±â¾÷Àº À¯ÇØ»ç·Êº¸°í(REAS)³ª ¾ÈÀü¼º º¸°í¼­ ÀÛ¼º µîÀÇ µ¥ÀÌÅÍ ºÐ¼®¿¡ À־ÀÇ °³¹ßÀ» ÅëÇØ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©ÀÇ °­È­¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 8¿ù, ¸ß½ÃÄÚ ³ó¾÷ ³óÃÌ °³¹ß¼ºÀº »õ·Î¿î µ¿¹°¿ë ¾à¹°°¨½Ã ½Ã½ºÅÛÀ» ½ÃÀÛÇß½À´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ¸ß½ÃÄÚ¿¡¼­ µ¿¹° ÀǾàǰÀÇ ¾ÈÀü¼º, ǰÁú ¹× È¿´ÉÀ» º¸ÀåÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. Á¦Ç°°ú °ü·ÃµÈ À§ÇèÀ» ½Äº°, Æò°¡ ¹× ¿ÏÈ­ÇÕ´Ï´Ù. ÀÌ ½Ã½ºÅÛ¿¡´Â ºÎÀÛ¿ëÀ» ¹®¼­È­Çϰí È¿´É, ÀÜ·ù ÇÑ°è ¹× È¯°æ¿¡ ¹ÌÄ¡´Â ¿µÇâ°ú °°Àº ¹®Á¦¸¦ ¸ð´ÏÅ͸µÇϱâ À§ÇÑ µ¿¹°¿ë ¾à¹°°¨½Ã °¡À̵å(REAS)°¡ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - °Å½Ã°æÁ¦ ½Ã³ª¸®¿À ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª ¹ÙÀÌ·¯½º °¨¿°ÀÇ ¿µÇâ°ú ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, Àü·«

Á¦36Àå ºÎ·Ï

KTH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Veterinary pharmacovigilance is the field focused on detecting, assessing, understanding, and preventing adverse effects or other drug-related issues in animals. It involves monitoring and evaluating the safety and efficacy of veterinary medicines after their approval. The aim is to ensure that the benefits of these medicines outweigh the risks, thus promoting animal health and welfare while also protecting human health and the environment.

The main types of veterinary pharmacovigilance are in-house and outsourced. In-house pharmacovigilance involves the monitoring and assessment of adverse drug reactions and safety-related data conducted by the pharmaceutical or veterinary company itself. This includes the use of software and services for products such as biologics and anti-infectives. The scope covers various animal types, including companion animals, livestock, and others. End users of these services include veterinary hospitals, veterinary companies, and academic and research institutes.

The veterinary pharmacovigilance market research report is one of a series of new reports from the business research company that provides veterinary pharmacovigilance market statistics, including veterinary pharmacovigilance industry global market size, regional shares, competitors with an veterinary pharmacovigilance market share, detailed veterinary pharmacovigilance market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary pharmacovigilance industry. This veterinary pharmacovigilance market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary pharmacovigilance market size has grown rapidly in recent years. It will grow from $0.81 billion in 2024 to $0.92 billion in 2025 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be attributed to increasing awareness of animal health, growth in the companion animal population, rising demand for livestock products, expanding veterinary services, and higher prevalence of zoonotic diseases.

The veterinary pharmacovigilance market size is expected to see rapid growth in the next few years. It will grow to $1.5 billion in 2029 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to increasing pet ownership and spending, rising veterinary expenditure, growing focus on animal welfare, expansion of telemedicine in veterinary services, and higher demand for personalized veterinary care. Major trends in the forecast period include adoption of digital reporting systems, expansion of telehealth services for veterinary care, integration of blockchain for data security, and development of cloud-based pharmacovigilance platforms.

The increasing demand for animal health and medicinal products is projected to drive the growth of the veterinary pharmacovigilance market. Animal health and medicine products include food, medications, and grooming items designed to support the health and well-being of pets. This growing demand is fueled by rising pet ownership, advances in veterinary medicine, and the need to boost livestock productivity. Moreover, greater awareness of animal welfare and a higher incidence of animal diseases are contributing to this surge. Veterinary pharmacovigilance plays a crucial role in pet care by ensuring the safety and effectiveness of medications through monitoring and assessing adverse effects and ensuring regulatory compliance. For example, the Republic of Estonia's Agency of Medicines (Ravimiamet) reported in March 2024 that the veterinary medicinal products sector grew by 6.9% in 2023, reaching 18.6 million euros, compared to 17.4 million euros in 2022. This growth in demand for animal health and medicinal products is expected to drive the veterinary pharmacovigilance market.

Key companies in the veterinary pharmacovigilance sector are concentrating on enhancing regulatory frameworks through developments in data analytics, such as adverse event reporting (REAS) and safety report preparation. These processes involve documenting and analyzing harmful reactions to veterinary drugs to assess safety and ensure compliance with regulatory standards. For instance, in August 2024, Mexico's Ministry of Agriculture and Rural Development launched a new veterinary pharmacovigilance system. Developed by SENASICA, this system aims to ensure the safety, quality, and efficacy of veterinary drugs in Mexico. It gathers data on adverse reactions from various stakeholders, including pharmaceutical companies, distributors, veterinary hospitals, and veterinarians, to identify, assess, and mitigate risks associated with these medications. The system includes the veterinary pharmacovigilance guide (REAS) for documenting adverse reactions and monitoring issues such as efficacy, residue limits, and environmental impacts.

In January 2024, Veterinary Pharmaceutical Solutions, a US-based company specializing in veterinary services, acquired Diamond Animal Health, Inc. for an undisclosed amount. This acquisition is intended to expand Veterinary Pharmaceutical Solutions' product range, enhance its research and development capabilities, and improve operational efficiencies within the animal health industry. Diamond Animal Health Inc. is a US-based contract manufacturing and research firm offering regulatory affairs consulting, a component of veterinary pharmacovigilance services.

Major companies operating in the veterinary pharmacovigilance market are Accenture PLC, Zoetis Inc, Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Covetrus Inc, IDEXX Laboratories, Inc., Ceva Sante Animale, Virbac SA, Merck Animal Health, Huvepharma EOOD, Norbrook Laboratories Ltd, ProPharma Group, ArisGlobal LLC, PQE Group, Chanelle Pharma Group Ltd, Clinvet International, Ennov SAS, Sarjen Systems Pvt. Ltd, PharSafer Associates Ltd, Medfiles Oy, Azierta Contract Science Support Consulting, Knoell Germany GmbH, Triveritas Ltd, Leon Research, Biologit, Indivirtus Group

North America was the largest region in the veterinary pharmacovigilance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary pharmacovigilance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary pharmacovigilance market consists of revenues earned by entities by providing services such as monitoring adverse drug reactions, assessing medication safety, collecting and analyzing safety data, conducting risk management, and ensuring regulatory compliance for veterinary medicines. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary pharmacovigilance market also includes sales of databases, reporting systems, safety assessment tools, and monitoring devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Pharmacovigilance Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary pharmacovigilance market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for veterinary pharmacovigilance ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary pharmacovigilance market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Veterinary Pharmacovigilance Market Characteristics

3. Veterinary Pharmacovigilance Market Trends And Strategies

4. Veterinary Pharmacovigilance Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Veterinary Pharmacovigilance Growth Analysis And Strategic Analysis Framework

6. Veterinary Pharmacovigilance Market Segmentation

7. Veterinary Pharmacovigilance Market Regional And Country Analysis

8. Asia-Pacific Veterinary Pharmacovigilance Market

9. China Veterinary Pharmacovigilance Market

10. India Veterinary Pharmacovigilance Market

11. Japan Veterinary Pharmacovigilance Market

12. Australia Veterinary Pharmacovigilance Market

13. Indonesia Veterinary Pharmacovigilance Market

14. South Korea Veterinary Pharmacovigilance Market

15. Western Europe Veterinary Pharmacovigilance Market

16. UK Veterinary Pharmacovigilance Market

17. Germany Veterinary Pharmacovigilance Market

18. France Veterinary Pharmacovigilance Market

19. Italy Veterinary Pharmacovigilance Market

20. Spain Veterinary Pharmacovigilance Market

21. Eastern Europe Veterinary Pharmacovigilance Market

22. Russia Veterinary Pharmacovigilance Market

23. North America Veterinary Pharmacovigilance Market

24. USA Veterinary Pharmacovigilance Market

25. Canada Veterinary Pharmacovigilance Market

26. South America Veterinary Pharmacovigilance Market

27. Brazil Veterinary Pharmacovigilance Market

28. Middle East Veterinary Pharmacovigilance Market

29. Africa Veterinary Pharmacovigilance Market

30. Veterinary Pharmacovigilance Market Competitive Landscape And Company Profiles

31. Veterinary Pharmacovigilance Market Other Major And Innovative Companies

32. Global Veterinary Pharmacovigilance Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Veterinary Pharmacovigilance Market

34. Recent Developments In The Veterinary Pharmacovigilance Market

35. Veterinary Pharmacovigilance Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â